Drug Type Small molecule drug |
Synonyms Lexanopadol, GRT-13106G (free base), GRT-6006 (free base) |
Target |
Mechanism OOR agonists(Nociceptin receptor agonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25FN2O |
InChIKeyAMXGKMSRYLZAEO-YHBQERECSA-N |
CAS Registry1357348-09-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Contraception | Phase 2 | CN | - | |
Pain | Phase 2 | - | - | |
Pain | Phase 2 | - | - |